NRSN ($NRSN) Insider Trading & Smart Money Activity

NRSN · Biotechnology · Latest filing Jun 16, 2026

$NRSN has 4 insider trades on file. In the last 12 months on the open market, 2 insiders bought ($800K) and no insider sold, net +$800K.

Insider buyers (12 mo)
2
Insider sellers (12 mo)
0
Net insider $ (12 mo)
+$800K
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

NRSN insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 4 · $800K 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All NRSN insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Or EisenbergChief Financial Officer Buy (Open-market buy) 250K sh $200K +9.9%+0.4% —
Insider Or EisenbergChief Financial Officer Buy (Open-market buy) 250K sh $200K +9.9%+0.4% —
Insider Alon Ben-NoonChief Executive Officer Buy (Open-market buy) 250K sh $200K +9.9%+0.4% —
Insider Alon Ben-NoonChief Executive Officer Buy (Open-market buy) 250K sh $200K +9.9%+0.4% Read

1W / 1M / 6M = how NRSN moved from the trade or filing date.

Insider trading in NRSN: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Or Eisenberg Chief Financial Officer 2 +$400K Jun 16, 2026
Alon Ben-Noon Chief Executive Officer 2 +$400K Jun 16, 2026

Frequently asked questions

Are NRSN insiders buying or selling?

Over the last 12 months 2 insiders made 4 open-market purchases worth $800K and 0 insiders made 0 open-market sales worth $0, a net +$800K.

What is the latest insider trade in NRSN?

Or Eisenberg, Chief Financial Officer filed a buy (open-market buy) of 250K sh worth $200K on Jun 16, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text